Dr. Cyrus Karkaria, President, Lupin Limited and Head of the Lupin Biological Research Program said "The multi-billion dollar opportunity with blockbuster Biologics going off patent in the next 5-8 years is something that Lupin is pursuing aggressively.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)